Notably, an international multicenter study with a large cohort of cases developed a DL model based on the entire lung, which achieved an AUC of 0.812 in predicting EGFR status in lung cancer and successfully stratified progression‐free survival in patients treated with EGFR‐TKI. The gene discussed is EGFR; the disease is lung cancer.